Emanuela Bonoldi
Overview
Explore the profile of Emanuela Bonoldi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
624
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Caputo V, Bonoldi E, Schroeder J, Rongioletti F
Ital J Dermatol Venerol
. 2025 Mar;
PMID: 40047373
No abstract available.
2.
Acanfora G, Iaccarino A, Cerbelli B, Di Cristofano C, Bellevicine C, Barberis M, et al.
Cancer Cytopathol
. 2025 Feb;
133(3):e70003.
PMID: 39992702
Introduction: The aim of this project is to assess interobserver agreement for programmed death-ligand 1 (PD-L1) scoring on of non-small cell lung cancer (NSCLC) on cytological specimens in a large-scale...
3.
Secco S, Olivero A, Tappero S, Delloglio P, Carbonaro L, Marando A, et al.
Cancer Pathog Ther
. 2025 Jan;
3(1):81-84.
PMID: 39872365
No abstract available.
4.
Macagno M, Pessei V, Congiusta N, Lazzari L, Bellomo S, Idrees F, et al.
Diagnostics (Basel)
. 2024 Nov;
14(22).
PMID: 39594133
is responsible for the direct repair of O6-methylguanine lesions induced by alkylating agents, including temozolomide. promoter hypermethylation is a well-established biomarker for temozolomide response in glioblastoma patients, also correlated with...
5.
Belloni E, Bonoldi E, Bovo G, Buoro S, Cerati M, Cribiu F, et al.
Pathologica
. 2024 Oct;
116(4):232-241.
PMID: 39377505
Objective: Digital pathology is an opportunity to revise the routine and old artisanal workflow, moving to standard operating procedures, quality control and reproducibility. Here the results of a survey promoted...
6.
Sartore-Bianchi A, Marsoni S, Amatu A, Torri V, Bonoldi E, Bardelli A, et al.
J Clin Oncol
. 2024 Jul;
42(30):3631-3632.
PMID: 39079079
No abstract available.
7.
Cazzato G, Colagrande A, Caputo V, Ingravallo G, Cascardi E, Fortarezza F, et al.
Dermatopathology (Basel)
. 2024 Jul;
11(3):209-217.
PMID: 39051324
A cutaneous carcinosarcoma (cCS) is a rare and aggressive skin cancer characterized by both carcinomatous (epithelial) and sarcomatous (mesenchymal) components, making it a biphasic tumor. Despite its occurrence in various...
8.
Zagni M, Marando A, Negrelli M, Lauricella C, Motta V, Paglino G, et al.
Pathologica
. 2024 Jul;
116(3):163-169.
PMID: 38979590
The 5th WHO classification of thoracic tumours includes thoracic SMARCA4-deficient undifferentiated tumour (SMARCA4-UT) among the "other epithelial tumours of the lung" chapter. Herein, we present a case of undifferentiated thoracic...
9.
Eccher A, Seminati D, LImperio V, Casati G, Pilla D, Malapelle U, et al.
J Pers Med
. 2024 Apr;
14(4).
PMID: 38672960
In the molecular era, proper archival conditions within pathology laboratories are crucial, especially for formalin-fixed paraffin-embedded (FFPE) tissue specimens retrieved years after the original diagnosis. Indeed, improper preservation can impact...
10.
Marando A, Zagni M, Negrelli M, Valtorta E, Lauricella C, Motta V, et al.
Pathologica
. 2024 Mar;
116(1):13-21.
PMID: 38482671
The WHO Classification of Tumors, Thoracic Tumors, 5th edition, has outlined the use of TTF-1 and ΔNP63/P40 to discriminate between adenocarcinoma and squamous cell carcinoma. In 2015, the first description...